Discontinuation report THALLIUM
Report ID | 161424 |
Drug Identification Number | 02327945 |
Brand name | THALLIUM |
Common or Proper name | thallous chloride Tl 201 |
Company Name | LANTHEUS MI CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | THALLIUM CHLORIDE |
Strength(s) | 2MCI |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 mL vial |
ATC code | V09GX |
ATC description | |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-12-31 |
Actual discontinuation date | |
Remaining supply date | 2022-12-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Barring unforeseen issues, supply will be available until the discontinuation date |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2X6 |
Company contact information | lmicanada@lantheus.com 1-800-811-5500 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-05-27 | French | Compare |
v2 | 2022-05-27 | English | Compare |
v1 | 2022-05-27 | English | Compare |
Showing 1 to 3 of 3